<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02695277</url>
  </required_header>
  <id_info>
    <org_study_id>CP2015-1</org_study_id>
    <nct_id>NCT02695277</nct_id>
  </id_info>
  <brief_title>Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation</brief_title>
  <acronym>CEASE-AF</acronym>
  <official_title>Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AtriCure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cardialysis BV</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>AtriCure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized (2:1) multicenter trial to investigate the optimal
      treatment of Persistent and Longstanding Persistent AF referred for Radiofrequency (RF)
      ablation.The study objective is to compare the efficacy and safety of two interventional
      approaches, in preventing the recurrence of AF in symptomatic, drug refractory patients with
      persistent or longstanding persistent atrial fibrillation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of subjects free from documented Atrial Fibrillation (AF), Atrial Flutter (AFL) or Atrial Tachycardia (AT) episodes &gt; 30 seconds in duration through 12 months follow-up, in the absence of Class I or III Antiarrhythmic Drugs (AADs).</measure>
    <time_frame>Through 12-months post the Endocardial procedure (Hybrid Procedure) or last allowed Catheter Ablation(Catheter Procedure)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of subjects free from documented AF, AFL or AT episodes &gt; 30 seconds in duration through 24 and 36 months follow-up, in the absence of Class I or III AADs.</measure>
    <time_frame>Through 24- and 36-months post the Endocardial procedure (Hybrid Procedure) or last allowed Catheter Ablation(Catheter Procedure)</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Composite major complications</measure>
    <time_frame>Up to 180 days (6-months) post index procedure</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Persistent and Longstanding Persistent Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Hybrid Procedure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endoscopic epicardial surgical ablation (first stage) combined with endocardial catheter ablation (second stage) performed between 91 and 180 days post index procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Catheter Procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard catheter ablation with pulmonary vein (PV) isolation (minimum lesion set) and optional additional lesions (index procedure). When required due to AF recurrence, ablation may be repeated within 6 months after the index-procedure according to clinical indications and consistent with the Heart Rhythm Society (HRS)/European Heart Rhythm Association (EHRA)/European Cardiac Arrhythmia Society (ECAS) Consensus Statement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AtriCure Bipolar System</intervention_name>
    <arm_group_label>Hybrid Procedure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard Endocardial Ablation with Catheter</intervention_name>
    <arm_group_label>Catheter Procedure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AtriClip® PRO LAA Exclusion System</intervention_name>
    <arm_group_label>Hybrid Procedure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endocardial Ablation with Catheter</intervention_name>
    <arm_group_label>Hybrid Procedure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Repeated Endocardial ablation(s)</intervention_name>
    <arm_group_label>Catheter Procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient has a history of symptomatic Persistent AF and a left atrium (LA) &gt; 4cm or
             Long Standing Persistent AF as defined by the HRS/EHRA/ECAS expert consensus statement

          2. Patient is refractory to or intolerant of at least one antiarrhythmic drug (class I or
             III)

          3. Patient is mentally able and willing to give informed consent

        Exclusion Criteria:

          1. Patient has longstanding persistent AF &gt; 10 years

          2. Patient presenting with paroxysmal AF

          3. Patient with persistent AF and a LA-diameter ≤ 4cm

          4. AF is secondary to electrolyte imbalance, thyroid disease, or other reversible or
             non-cardiovascular cause

          5. Patient underwent previous ablation procedure or heart surgery

          6. Patient needs other cardiac surgery procedures besides AF treatment (valve, coronary,
             others)

          7. Contraindication for either catheter ablation or epicardial surgery (including, but
             not limited to: previous thoracic radiation, previous perimyocarditis, Previous
             cardiac tamponade, Pleural adhesions, Prior thoracotomy)

          8. Body mass index &gt; 35

          9. LA Diameter &gt; 6 cm

         10. Left ventricular ejection fraction &lt; 30 %

         11. Severe mitral regurgitation (&gt;II)

         12. Patient unable to undergo TransEsophageal Echocardiogram (TEE)

         13. Presence of LA thrombus by TEE, CT scan, MRI or angiography

         14. History of cerebrovascular disease, including stroke or transient ischemic attack
             (TIA) within 6 months prior to enrollment

         15. Active infection or sepsis

         16. Other clinical conditions precluding inclusion (e.g., organ disease, disturbances of
             hemostasis)

         17. Contraindication to anticoagulant therapy, or inability to comply with anticoagulant
             therapy

         18. Pregnancy, planned pregnancy or breastfeeding

         19. Life expectancy is less than 12 months

         20. Patient is involved in another study involving an investigational drug or device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Erik Fransen, MSc, PhD</last_name>
    <email>efransen@atricure.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shana Zink</last_name>
    <email>szink@atricure.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Czech Budejovice Hospital, Inc.</name>
      <address>
        <city>Budweis</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Center Bad Neustadt</name>
      <address>
        <city>Bad Neustadt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Schüchtermann-Schiller'sche Kliniken Herzzentrum Osnabrück</name>
      <address>
        <city>Bad Rothenfelde</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Heart Center Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Surgeon: Prof. Dr. Martin Misfeld</last_name>
    </contact>
    <contact_backup>
      <last_name>Electrophysiologist: Prof. Dr. Gerhard Hindricks</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Klinikum Ludwigsburg</name>
      <address>
        <city>Ludwigsburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Peter Osypka Heart Center Munich</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kliniken Sindelfingen</name>
      <address>
        <city>Sindelfingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sana Heart Center Stuttgart</name>
      <address>
        <city>Stuttgart</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prof. Dr. Kai-Nicolas Doll</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Surgeon: Dr. Bart van Putte</last_name>
    </contact>
    <contact_backup>
      <last_name>Electrophysiologist: Dr. Maurits Wijffels</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Central Clinical Hospital of the Ministry of Interior</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Northern General Hospital</name>
      <address>
        <city>Sheffield</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2015</study_first_submitted>
  <study_first_submitted_qc>February 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2016</study_first_posted>
  <last_update_submitted>September 14, 2017</last_update_submitted>
  <last_update_submitted_qc>September 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Persistent and Longstanding Persistent AF</keyword>
  <keyword>Hybrid Procedure</keyword>
  <keyword>Catheter Ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

